Decoy Therapeutics Inc. Cash And Cash Equivalents At Carrying Value

• Decoy Therapeutics Inc. showed an increase of +339.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Decoy Therapeutics Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 44.2%.
• Historical annual values: Fiscal year 2025: $10.71 million | Fiscal year 2024: $2.43 million | Fiscal year 2023: $5.90 million | Fiscal year 2022: $12.11 million | Fiscal year 2021: $29.21 million | Fiscal year 2020: $11.12 million | Fiscal year 2019: $3.74 million | Fiscal year 2018: $3.23 million | Fiscal year 2017: $19.19 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026